Vivos Therapeutics, Inc. Operating Lease Cost
Vivos Therapeutics, Inc. (VVOS) reported Operating Lease Cost of $1.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-04-15
- Vivos Therapeutics, Inc. operating lease, cost for the quarter ending 2024-06-30 was $123.00K, a 7.89% increase year-over-year.
- Vivos Therapeutics, Inc. operating lease, cost for the quarter ending 2024-03-31 was $123.00K, a 5.38% decline year-over-year.
- Vivos Therapeutics, Inc. operating lease, cost for the quarter ending 2023-12-31 was $110.00K, a 42.86% increase year-over-year.
- Vivos Therapeutics, Inc. operating lease, cost for the quarter ending 2023-09-30 was $128.00K, a 13.51% decline year-over-year.
- Vivos Therapeutics, Inc. operating lease, cost for fiscal 2025 was $1.04M, a 114.91% increase from fiscal 2024.
- Vivos Therapeutics, Inc. operating lease, cost for fiscal 2024 was $483.00K, a 0.42% increase from fiscal 2023.
- Vivos Therapeutics, Inc. operating lease, cost for fiscal 2023 was $481.00K, a 1.23% decline from fiscal 2022.
- Vivos Therapeutics, Inc. operating lease, cost for fiscal 2022 was $487.00K, a 16.47% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $1.04M 10-K · filed 2026-04-15 | ||||
| 2024-12-31 | $483.00K 10-K · filed 2026-04-15 | ||||
| 2024-06-30 | $123.00K 10-Q · filed 2024-08-14 | $247.00K 10-Q · filed 2024-08-14 | $356.00K derived: sum of 3 quarters · filed 2025-03-31 | $484.00K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2024-03-31 | $123.00K 10-Q · filed 2024-05-14 | $233.00K derived: sum of 2 quarters · filed 2025-03-31 | $361.00K derived: sum of 3 quarters · filed 2025-03-31 | $475.00K derived: sum of 4 quarters · filed 2025-03-31 | |
| 2023-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $238.00K derived: sum of 2 quarters · filed 2025-03-31 | $352.00K derived: sum of 3 quarters · filed 2025-03-31 | $481.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $128.00K 10-Q · filed 2023-11-14 | $242.00K derived: sum of 2 quarters · filed 2024-08-14 | $371.00K 10-Q · filed 2023-11-14 | $449.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-06-30 | $114.00K 10-Q · filed 2024-08-14 | $243.00K 10-Q · filed 2024-08-14 | $321.00K derived: sum of 3 quarters · filed 2024-08-14 | $469.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $130.00K 10-Q · filed 2024-05-14 | $207.00K derived: sum of 2 quarters · filed 2024-07-30 | $355.00K derived: sum of 3 quarters · filed 2024-07-30 | $490.00K derived: sum of 4 quarters · filed 2024-07-30 | |
| 2022-12-31 | $77.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | $225.00K derived: sum of 2 quarters · filed 2024-07-30 | $360.00K derived: sum of 3 quarters · filed 2024-07-30 | $487.00K 10-K/A · filed 2024-07-30 | |
| 2022-09-30 | $148.00K 10-Q · filed 2023-11-14 | $283.00K derived: sum of 2 quarters · filed 2023-11-14 | $410.00K 10-Q · filed 2023-11-14 | $471.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $135.00K 10-Q · filed 2023-08-16 | $262.00K 10-Q · filed 2023-08-16 | $323.00K derived: sum of 3 quarters · filed 2023-08-16 | $392.00K derived: sum of 4 quarters · filed 2023-08-16 | |
| 2022-03-31 | $127.00K 10-Q · filed 2023-06-08 | $2.67M 10-Q · filed 2022-05-16 | $188.00K derived: sum of 2 quarters · filed 2023-06-08 | $257.00K derived: sum of 3 quarters · filed 2023-06-08 | $578.00K derived: sum of 4 quarters · filed 2023-06-08 |
| 2021-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $130.00K derived: sum of 2 quarters · filed 2023-03-30 | $451.00K derived: sum of 3 quarters · filed 2023-03-30 | $583.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $69.00K 10-Q · filed 2022-12-20 | $390.00K derived: sum of 2 quarters · filed 2022-12-20 | $522.00K 10-Q · filed 2022-12-20 | ||
| 2021-06-30 | $321.00K 10-Q · filed 2022-12-20 | $452.00K 10-Q · filed 2022-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |